FDA Drug Application (201845) for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE by CADISTA PHARMS

Back to FDA Applications sponsored by CADISTA PHARMS

Application Number201845
Product Number001
FormTABLET;ORAL
Dosage12.5MG;50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient LOSARTAN POTASSIUM4


Back to FDA Applications sponsored by CADISTA PHARMS